The Bevacizumab, cataloged under National Stock Number 6505-01-566-7532, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Genentech Inc. The record lists 1 manufacturer part number for this item, enabling identification through both NSN and commercial part number lookups. 1 additional reference document (drawings, advisory and superseded references) is recorded in the U.S. Government catalog. Current acquisition status: Active.
| Parameter | Value |
|---|---|
| NSN | 6505-01-566-7532 |
| Primary Part Number | AVASTIN 25MG/ML 4ML |
| Item Name | Bevacizumab |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Genentech Inc |
| Status | ACTIVE |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Possible hazard — SDS may be required (DLA HMIC P) |
| Criticality Code | X |
| Part Number | Manufacturer |
|---|---|
| AVASTIN 25MG/ML 4ML PRIMARY | Genentech Inc (USA) |
| Reference | Meaning |
|---|---|
| AVASTIN 25MG/ML 4ML | 5/9 Secondary reference Barenboim S.a. |
NSN 6505-01-566-7532 is a Bevacizumab, manufactured by Genentech Inc, classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-566-7532 has 1 manufacturer part number on file: AVASTIN 25MG/ML 4ML (Genentech Inc).
Key specifications for AVASTIN 25MG/ML 4ML: Special Features: DESIGNED TO INHIBIT ANGIOGENESIS,THE PROCESS BY WHICH NEW BLOOD VESSELS DEVELOP AND CARRY VITAL NUTRIENTS TO A TUMOR;SINGLE USE GLASS VIAL TO DELIVER 100 MG PER VIAL;MUST BE REFRIGERATED AT 2-8DEG C(36-46DEG F) AND PROTECTED FROM LIGHT DEGC. 0 specifications are documented in the U.S. Government catalog.
Possible hazard — SDS may be required (DLA HMIC P). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.